The multivariate analysis showed that KIF2A expression (P = 0.016), serum LDH level (P = 0.049), and IPI score (P < 0.001) were robust prognostic markers for patients with DLBCL (Table 2). This evidence concerns the gene KIF2A and diffuse large B-cell lymphoma.